We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Neurological Disease Traced to Gene Error

By LabMedica International staff writers
Posted on 15 Aug 2017
A severe neurological rare disorder in children is characterized by developmental regression and neurodegeneration and at first the children lead normal lives and seem identical to their age-matched peers.

However, beginning at around three to six years of age, these children present with neurological deterioration, gradually losing motor, cognitive and speech functions. More...
Although the condition progresses slowly, most patients are completely dependent on their caretakers by 15 to 20 years of age.

A multinational team of scientists collaborating with those at those at the Hebrew University Hadassah Medical School (Jerusalem, Israel) identified and studied seven children, from Canada, France, Israel, Russia and the USA, who suffer from the disorder. They found in all patients the same spontaneously occurring, non-inherited genetic change in the upstream binding transcription factor (UBTF) gene responsible for ribosomal ribonucleic acid (rRNA) formation. Because of this small change, the patients' cells are flooded with ribosomal RNA and are poisoned by it.

In seven unrelated affected individuals, all suffering from developmental regression starting at 2.5 to 7 years, the team using deep sequencing technology, identified a heterozygous variant, c.628G>A in UBTF, encoding p.Glu210Lys in UBF, which occurred de novo in all cases. The team found an identical error in the same gene in all the patients tested, representing a difference of one letter among the roughly three billion letters that make up human DNA. By finding the identical change in children who suffer from the identical clinical disease, the scientists determined that the altered gene is indeed the cause of the disease.

Orly Elpeleg, MD, a professor and head of the Department of Genetics, and senior author of the study, said, “Our study links neuronal degeneration in childhood with altered rDNA chromatin status and rRNA metabolism. It is the first time that an excess of ribosomal RNA has been linked to a genetic disease in humans.” The study was published on August 3, 2017, in The American Journal of Human Genetics.

Related Links:
Hebrew University Hadassah Medical School


Gold Member
H-FABP Assay
Heart-Type Fatty Acid-Binding Protein Assay
Online QC Software
Acusera 24•7
Automated Coagulation Analyzer
Hemolumi H6
Manual Pipetting Aid
Pipette Controllers macro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The approach supports myocardial infarction diagnosis in resource-limited settings by reducing delays between clinical suspicion and biochemical confirmation (Image Credit: Adobe Stock)

Portable Troponin Assay Brings Heart Attack Diagnosis Closer to Patients

Timely confirmation of myocardial infarction often depends on laboratory testing that may not be immediately available at the point of care. This gap between clinical suspicion and definitive evidence... Read more

Microbiology

view channel
Image: An innovative countywide program in Taiwan combines risk-based screening with decentralized community care to improve hepatitis C detection and treatment (Image Credit: iStock)

Precision Screening Helps Close Hepatitis C Diagnosis and Treatment Gaps

Hepatitis C remains a leading cause of cirrhosis and liver cancer, yet many infections go undiagnosed or untreated because health systems fail to reach those at greatest risk. Although highly effective... Read more

Pathology

view channel
Image: Through the PCCP, Proscia gains a more efficient pathway to expand Concentriq AP-Dx interoperability while maintaining regulatory oversight (Photo courtesy of Proscia)

FDA-Cleared Digital Pathology Platform Expands Interoperability for Primary Diagnosis

Rising cancer incidence is colliding with a shrinking pathologist workforce, intensifying pressure on diagnostic turnaround times in clinical laboratories. Many labs are adopting digital pathology to manage... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.